Indeed, our preliminary and published studies support this hypothesis by demonstrating that sub-chronic administration (7 days) of nicotine, a non-selective α7-nAChR agonist, protected kidneys by significantly reducing renal inflammation and renal injury in a mouse model of SLE (26). Here, CHRNA7 is linked to systemic lupus erythematosus.